Literature DB >> 33445002

A comprehensive review on the neuropathophysiology of selenium.

Mohammad Naderi1, Pankaj Puar2, Mahtab Zonouzi-Marand2, Douglas P Chivers3, Som Niyogi4, Raymond W M Kwong2.   

Abstract

As an essential micronutrient, selenium (Se) exerts its biological function as a catalytic entity in a variety of enzymes. From a toxicological perspective, however, Se can become extremely toxic at concentrations slightly above its nutritional levels. Over the last few decades, there has been a growing level of concern worldwide regarding the adverse effects of both inorganic and organic Se compounds on a broad spectrum of neurological functions. A wealth of evidence has shown that exposure to excess Se may compromise the normal functioning of various key proteins, neurotransmitter systems (the glutamatergic, dopaminergic, serotonergic, and cholinergic systems), and signaling molecules involved in the control and regulation of cognitive, behavioral, and neuroendocrine functions. Elevated Se exposure has also been suspected to be a risk factor for the development of several neurodegenerative and neuropsychiatric diseases. Nonetheless, despite the various deleterious effects of excess Se on the central nervous system (CNS), Se neurotoxicity and negative behavioral outcomes are still disregarded at the expense of its beneficial health effects. This review focuses on the current state of knowledge regarding the neurobehavioral effects of Se and discusses its potential mode of action on different aspects of the central and peripheral nervous systems. This review also provides a brief history of Se discovery and uses, its physicochemical properties, biological roles in the CNS, environmental occurrence, and toxicity. We also review potential links between exposure to different forms of Se compounds and aberrant neurobehavioral functions in humans and animals, and identify key knowledge gaps and hypotheses for future research.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Central nervous system; Neurobehavioral abnormality; Neurotoxicity; Selenium

Year:  2020        PMID: 33445002     DOI: 10.1016/j.scitotenv.2020.144329

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  5 in total

1.  Serum selenium and non-alcoholic fatty liver disease (NAFLD) in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2011-2016.

Authors:  Xin Wang; Young Ah Seo; Sung Kyun Park
Journal:  Environ Res       Date:  2021-04-16       Impact factor: 8.431

2.  The Effect of Selenium Supplementation on Clinical Outcomes, Metabolic Profiles, and Pulsatility Index of the Uterine Artery in High-Risk Mothers in Terms of Preeclampsia Screening with Quadruple Test: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial : Selenium and preeclampsia.

Authors:  Elahe Mesdaghinia; Farah Shahin; Amir Ghaderi; Daryoush Shahin; Mohammad Shariat; Hamidreza Banafshe
Journal:  Biol Trace Elem Res       Date:  2022-02-28       Impact factor: 3.738

3.  Associations of Dietary Copper, Selenium, and Manganese Intake With Depression: A Meta-Analysis of Observational Studies.

Authors:  Jun Ding; Yi Zhang
Journal:  Front Nutr       Date:  2022-03-15

4.  Selenoprotein P Concentrations in the Cerebrospinal Fluid and Serum of Individuals Affected by Amyotrophic Lateral Sclerosis, Mild Cognitive Impairment and Alzheimer's Dementia.

Authors:  Teresa Urbano; Marco Vinceti; Jessica Mandrioli; Annalisa Chiari; Tommaso Filippini; Roberta Bedin; Manuela Tondelli; Cecilia Simonini; Giovanna Zamboni; Misaki Shimizu; Yoshiro Saito
Journal:  Int J Mol Sci       Date:  2022-08-30       Impact factor: 6.208

5.  Selenium Intake and its Interaction with Iron Intake Are Associated with Cognitive Functions in Chinese Adults: A Longitudinal Study.

Authors:  Ke Jiang; Changxiao Xie; Zhourong Li; Huan Zeng; Yong Zhao; Zumin Shi
Journal:  Nutrients       Date:  2022-07-22       Impact factor: 6.706

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.